FDA
-
-
-
-
-
-
-
Citius Oncology Expands International Distribution of LYMPHIRâ„¢ to European Union Through Exclusive Agreement with Uniphar
-
-
-
-
-
-
-
Citius Oncology Announces $18 Million Concurrent Registered Direct Offering and Private Placement Priced At-The-Market Under Nasdaq Rules
-
-
-
-
-
-
-
Citius Pharmaceuticals closes $6 million direct offering
-
-
-
-
-
-
-
Citius Oncology partners with EVERSANA for LYMPHIR drug launch
-
-
-
-
-
-
-
Citius Oncology deploys AI platform ahead of LYMPHIR launch
-
-
-
-
-
-
-
Citius Oncology prices $9 million public offering at $1.32 per share
-
-
-
-
-
-
-
Citius Oncology Anticipates Commercial Launch of LYMPHIRâ„¢ in 2025
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

